Healthcare Industry
Filter News
Found 6,311 articles
-
St. Jude Children’s Research Hospital published data from its Phase I/II clinical trial of its gene therapy for SXCID or SCID-X1, also dubbed “bubble boy disease.” The research was published in the New England Journal of Medicine.
-
Pharma and biotechs from across the globe share news, pipeline updates, with stories from Vetter, Atomwise, Tessa, GenSight, and more.
-
IMV to Provide Updated Clinical Data at 2019 ASCO Annual Meeting on Lead Candidate DPX-Survivac in Ovarian Cancer and Other Solid Tumors
4/18/2019
IMV Inc. announced that two of its abstracts have been accepted for presentation at the upcoming 2019 American Society of Clinical Oncology Annual Meeting, which takes place May 31 – June 4 in Chicago, IL.
-
ViewRay Partners with Leading Canadian Distributor to Bring MRI-guided Radiation Therapy to Canada
4/18/2019
Minogue Medical to Serve as Exclusive Canadian Distributor for ViewRay's MRIdian System
-
Acorda First Quarter 2019 Update: Webcast/Conference Call Scheduled for May 2, 2019
4/18/2019
Acorda Therapeutics, Inc. will host a conference call and webcast to report its first quarter 2019 update and financial results on Thursday, May 2 at 8:30 a.m. ET.
-
Encompass Health to present at Bank of America Merrill Lynch Health Care Conference
4/18/2019
Encompass Health Corp. announced it will participate in the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada being held May 14-16, 2019.
-
Cool Science News! We Want to Know
4/17/2019
The life science industry is continually making advancements in every area! We want to know what cool science innovations are currently in progress and the professionals behind them. -
PureTech, which has headquarters in Boston, but is listed in London, signed a research collaboration deal with Germany’s Boehringer Ingelheim. The companies will work to develop novel product candidates using PureTech’s proprietary lymphatic targeting technology for immune modulation.
-
CENTOGENE Appoints AI Industry Leader Dr. Carsten Ullrich as Director of Artificial Intelligence
4/17/2019
Research Fellow from German Research Center for Artificial Intelligence to lead team driving solutions for pharmaceutical partners
-
TherapeuticsMD Announces Commercial Availability of BIJUVA™ in the U.S.
4/17/2019
BIJUVA is the only FDA-approved Therapy Combining Bio-identical Estradiol and Progesterone for Moderate to Severe Vasomotor Symptoms due to Menopause in a Single Capsule
-
Nurx Appoints Varsha Rao as CEO
4/17/2019
Former Airbnb and Clover Health executive brings decades of experience to the mission-driven telemedicine company
-
TherapeuticsMD Signs Binding Commitment Letter for $300 Million Non-Dilutive Term Loan Financing Facility with TPG Sixth Street Partners
4/17/2019
Leading Healthcare Investor Will Provide TherapeuticsMD with Strategic Growth Capital
-
Golden Meditech and HKBU Team Up to Conduct Cell Therapy Research
4/17/2019
Golden Meditech Holdings Limited, a leading integrated healthcare enterprise in China, announced that it has formed a collaboration with the Department of Biology of Hong Kong Baptist University to conduct in-depth research in the area of cell therapy, particularly treating neurodegenerative diseases with stem cells.
-
ViewRay Partners with Largest Independent Distributor in Australia and New Zealand to Bring Benefits of MRI-Guided Radiation Therapy to the Region
4/17/2019
Device Technologies Australia to Help Expand Global MRIdian Adoption
-
The famous breast disease expert in China, Dr. Du Yutang, is committed to establishing a diagnosis and treatment center for GLM in Beijing Sanfine International Hospital
4/17/2019
In April 2019, the famous breast disease expert in China, Dr. Du Yutang, and his doctor's team officially joined Beijing Sanfine International Hospital.
-
Turning Point Therapeutics Announces Pricing of Initial Public Offering
4/17/2019
Turning Point Therapeutics, Inc. announced the pricing of its initial public offering of 9,250,000 shares of its common stock at a price to the public of $18.00 per share.
-
Crescita Therapeutics to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference in Toronto
4/17/2019
Crescita Therapeutics Inc., a Canadian commercial dermatology company, is pleased to announce that its President and CEO, Serge Verreault will be presenting at the upcoming Bloom Burton & Co.
-
Agendia Announces Creation of New Center of Innovation and R&D Excellence
4/17/2019
Simultaneous creation of Global Lab Center of Excellence
-
Pennsylvania Dental Association Installs Dr. Charles Incalcaterra as President
4/17/2019
The Pennsylvania Dental Association (PDA) recently installed Dr. Charles Incalcaterra of Orefield, Lehigh County, as its 2019-2020 President, at its annual meeting in Gettysburg.
-
Laguna Treatment Hospital Hosts Community Event on Underage Drinking
4/17/2019
'From Underage Drinking to Addiction: Stories and Stats We Can't Ignore' will also feature a former "Baywatch" TV star whose addiction started as a teenager with alcohol